The DOI matches its Crossref record; 179 of the 180 references it cites were found in a registry or an index.
Evaluation and management of heart failure with preserved ejection fraction
Abstract
Heart failure with preserved ejection fraction (HFpEF) has grown to become the dominant form of heart failure worldwide, in tandem with ageing of the general population and the increasing prevalences of obesity, diabetes mellitus and hypertension. The clinical syndrome of HFpEF is heterogeneous and must be distinguished from heart failure with reduced ejection fraction as well as other aetiologies that have different treatment strategies. The diagnosis of HFpEF is challenging and ultimately relates to the conceptual definition of heart failure as a clinical syndrome characterized by symptoms that are associated with a reduced capacity of the heart to pump blood adequately at normal filling pressures during diastole. Clinical trials to date have been largely unsuccessful in identifying effective treatments for HFpEF but evidence supports the use of diuretics, mineralocorticoid antagonists and lifestyle interventions. Pathophysiological heterogeneity in the presentation of HFpEF is substantial, and ongoing studies are underway to evaluate the optimal methods to classify patients into phenotypically homogeneous subpopulations to facilitate better individualization of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even if the diastolic dysfunction is the hemodynamic feature of HFpEF, the essence of its pathophysiology is the increase of LV filling pressure, meaning that the heart can adequately pump the blood at expense of an elevation of cardiac filling pressures that, if disproportionate during exercise or at rest, are responsible of dyspnea [102,103].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [102]
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,532
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Cited by
Sorted by citations
Items 601–680 of 680
Wang, R., Ye, H., Zhao, Y., Wei, J., Wang, Y., Zhang, X., & Wang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26555375
Xiong, Y., Liu, X., Jiang, L., Hao, T., Wang, Y., & Li, T. (2024) · Figshare · doi:10.6084/m9.figshare.26685288
Wang, R., Ye, H., Zhao, Y., Wei, J., Wang, Y., Zhang, X., & Wang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26555378
Feng, B., Yu, P., Yu, H., Qian, B., Li, Y., Sun, K., 施毕旻, Zhang, N., & Xu, G. (2024) · Figshare · doi:10.6084/m9.figshare.26600620
Feng, B., Yu, P., Yu, H., Qian, B., Li, Y., Sun, K., 施毕旻, Zhang, N., & Xu, G. (2024) · Figshare · doi:10.6084/m9.figshare.26600632
Xiong, Y., Liu, X., Jiang, L., Hao, T., Wang, Y., & Li, T. (2024) · Figshare · doi:10.6084/m9.figshare.26685294
Liu, J., Wang, D., Ruan, J., Wu, G., Xu, L., Jiang, W., Wang, J., Xiaolu, S., 康连鸣, & Song, L. (2022) · Figshare · doi:10.6084/m9.figshare.19070022
Feng, B., Yu, P., Yu, H., Qian, B., Li, Y., Sun, K., 施毕旻, Zhang, N., & Xu, G. (2024) · Figshare · doi:10.6084/m9.figshare.26600638
Greene, E. J. D., Arregun, R. S., Martínez, B. B., Salgado, K. P., & Silva, S. D. R. (2025) · Acta Médica Grupo Ángeles · doi:10.35366/122159
Lubis, A. (2025) · Asian Multidisciplinary Research Journal of Economy and Learning. · doi:10.70471/v6pn3r03
la Fuente, F. P.-D., Troncoso, M. F., Urquiza-Zurich, S., Silva, D., Díaz‐Vesga, M. C., Jiménez-Gallegos, D., Bascuñan, R., Ortega, A., Vivar, R., Muñoz-Rodríguez, C., et al. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124248
Li, W., Shen, X., Jiang, X., Shen, Y., Wen, H., Zhang, W., & Wen, J. (2026) · International Heart Journal · doi:10.1536/ihj.24-706
Transient Magnetic Resonance Elastography: a method to measure the mechanics of the active heartPreprint
Mota, M. B., Annio, G., Rucher, G., & Martorell, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.02.708995
Jin, K., Tang, Y., Zhan, J., Zhou, Y., Xie, R. R., Hu, G., Qin, Y., Wen, J., Wen, Z., Zhao, Y., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag067
Zhang, D., Wang, D., Wang, X., Yu, J., & Liu, B. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1790873
PGC-1α exacerbates apoptosis to induce HIF-1α/BNIP3 mediated mitophagy in heart failure
Ni, C., Hu, P., & Ni, Y. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153592
Diagnostik und Therapieansätze der Herzinsuffizienz mit erhaltener systolischer Funktion
Beyer, M., Mügge, A., Akın, İ., van Heerebeek, L., El‐Battrawy, I., & Hamdani, N. (2026) · Die Kardiologie · doi:10.1007/s12181-026-00807-6
Sodium glucose transporter 2 inhibitors for heart failure
Usuda, D., Furukawa, D., Imaizumi, R., Ono, R., Kaneoka, Y., Nakajima, E., Kato, M., Sugawara, Y., Shimizu, R., Inami, T., et al. (2026) · World Journal of Cardiology · doi:10.4330/wjc.v18.i3.118227
Issaka, Y., Abdul-Kareem, H., Meyahnwi, D., Ntow, M. A., & Hahn, S. S. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.03.055 · Cited by 1
Khalil, I., Hossain, I., Sarker, P., Nur, N., Al-Badri, S. G., Akter, M. M., Halder, L., Rahman, M. T., & Kamrul-Hasan, A. B. M. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.03.009
Li, Y., Chen, J., Zhao, J., & Xu, B. (2026) · Journal of Visualized Experiments · doi:10.3791/70135
Mutruc, V., Sîngeap, M. S., Bologa, C., Șorodoc, V., Petriș, O. R., Sîrbu, O., Morărașu, B. C., Corneanu, L. E., Jaba, E., Șorodoc, L., et al. (2026) · Medical Sciences · doi:10.3390/medsci14020167
Pieronne-Deperrois, M. (2022) · theses.fr (ABES) · doi:10.70675/71ef46cfz0230z4862za32aze1072fe4be66
Serum-to-hair Zn ratio as an index of zinc dyshomeostasis in HFpEF patients
Krasińska, B., Urbanowicz, T. K., Gabriel, K., Kasperowicz, Z., Adamczak, O., Spasenenko, I., Bartuś, K., Kowalewski, M., Krasiński, Z., Tykarski, A., et al. (2026) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2026.127870
Zhang, Y., Li, Y., Yang, X., Wang, X., Chen, S., Liu, T., Chuanbo, L. I. U., Wu, J., & Sun, Y. (2026) · Clinical Radiology · doi:10.1016/j.crad.2026.107348
Therapeutic potential of Relaxin-2 in Heart Failure with preserved Ejection Fraction (HFpEF)Preprint
Palma, J. B., Gabris-Weber, B. A., McMahon, B., Mauro, A. J., Hilaire, C. S., Cuevas, R. A., Dschietzig, T. B., Romero, G., & Salama, G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.14.725229
Losordo, L. D., Amin, G., Singla, M., Belk, S. S., Butler, K. R., Booz, G. W., & Monafo, A. (2026) · Pediatric Research · doi:10.1038/s41390-026-05038-9
Al‐Horani, R. A., & Goyal, N. (2026) · Drugs and Drug Candidates · doi:10.3390/ddc5020033
Islam, M. A., Asaduzzaman, M., & Abdullah, M. (2026) · TAJ Journal of Teachers Association · doi:10.70818/taj.v39i2.0754
Peng, B., & Zhang, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1877248
Ideta, M. M. L., Nihei, C. M. I., MOREIRA, P. H. B., & de Freitas, A. K. E. (2025) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20250043i
Ideta, M. M. L., Nihei, C. M. I., MOREIRA, P. H. B., & de Freitas, A. K. E. (2012) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20250043
Of Mice and Men: Toward Mouse‐Specific Diastolic Echocardiography
Harbo, M. B., & Espe, E. K. S. (2026) · Acta Physiologica · doi:10.1111/apha.70269
Semaglutide for the Silent Phenotype: A Translational Signal in Obesity-Driven HFpEF
Ceravolo, R., Lucà, F., Gulizia, M. M., Nardi, F., Grimaldi, M., & Gelsomino, S. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.06.015
Mavraganis, G., Fragoulis, C., Georgiopoulos, G. A., Mavromoustakou, K., Dimitriadis, K. P., Aznaouridis, K. A., Chrysohoou, C. A., Stamatelopoulos, K. S., & Tsioufis, K. P. (2026) · Medicina · doi:10.3390/medicina62071222
Anand, L., Lovell, T., Arulalan, S. L., Annie, F., Belcher, A. M., Pettry, C., Gharib, E. G., Dorairajan, S., & Chockalingam, A. (2026) · Cureus · doi:10.7759/cureus.111494
Kalesi, A. E., Papanastasiou, C. A., Alexandrou, K., Khattab, E., Patsourakos, N. G., & Kadoglou, N. P. E. (2026) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2026.103386
Tailored anesthesia protocols for echo-based HFpEF phenotyping in C57BL6/N mice
Wingert, J., Haase, L., Meinhardt, E., Frey, N., & Schlegel, P. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00319.2026
Chen, W., Sun, Y., Meng, C.-F., Wu, S.-T., Jiang, X.-Y., Xian-meng, M., & Wang, Q.-F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1870980 · Cited by 1
Ulutaş, Z., Yiğit, Y., Karaağaç, M., & Cansel, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135298
Srinivas, B., Alluri, K., Peng, H., Jiang, X., Fortuno, P., May, J. F., Moudden, I. E., Rhaleb, N., Herre, J. M., Benza, R. L., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03253-6
Santana, C., Katayama, A., Ballal, A., Sirish, P., Liem, D. A., Bidwell, J. T., Chen, C., Nuño, M., Ebong, I., Zhang, X.-D., et al. (2026) · medRxiv · doi:10.64898/2026.07.06.26357251
Self-citationLORENZO, R. D., & Rovere, P. Q. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108345
Luput-Andrica, I.-M., Marinescu, A.-R., Cut, T. G., Herlo, A., Laza, R., Oancea, C. I., Susa, S. R., Dumitrescu, A. S., Pescaru, C. C., & Lăzureanu, V. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156733
Youniszad, M. G., & Deng, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1881631
He, C., Zhao, H., Liu, H., Zhao, X., Zhang, M.-T., & Li, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1861971
Soglio, S. D., Beaulieu, M.-C., Lucinian, Y. A., Moazzami, C., Juneau, D., Amrouche, Y., Bouabdallaoui, N., Fontaine, V., Matteau, A., Mansour, S., et al. (2026) · CJC Open · doi:10.1016/j.cjco.2026.07.018
Shahverdi, E., Schulz, M., Schneider, C., & Lange, M. (2026) · Echocardiography · doi:10.1111/echo.70582
Anstadt, M. P., del Rio, C. L., Schmitt, B. A., & McConnell, P. I. (2026) · ASAIO Journal · doi:10.1097/mat.0000000000002803
Liu, F., Liu, X., He, Y., Liu, G., Lan, T., Zhao, Z., & Yang, F. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1913021
Shao, L., Li, Y., Xu, C., Tai, H., Wang, L., & Shi, J. (2026) · Research Square · doi:10.21203/rs.3.rs-10063256/v1
Li, T., Chen, Y., Xu, B., Li, J., & Meng, Y. (2026) · Artery Research · doi:10.1007/s44200-026-00127-w
Cheng, X., Ma, R., Guo, M., Wei, J., Zhao, Q., Yu, R. E., Dong, Z., Wang, J., Wang, Y., 朱明军, et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1902637
Xiao, W., Wang, Z., Yan, D., Peng, M., & Zhou, X. (2026) · Clinical Cardiology · doi:10.1002/clc.70446
Gioia, G., Seirer, B., Dusik, F., Rettl, R., Binder, C., Duca, F., Dalos, D., Eslam, R. B., Kästner, J., Thiele, H., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.049283
Moradi, A., Ramey, K., Tabbaa, K., Sahyouni, A., Garcez, K. S., KUMAR, S., Pan, E. H., Barton, G., Oyesanmi, O., & Subbiondo, R. J. (2026) · Pathophysiology · doi:10.3390/pathophysiology33030063
Current status on the role of beta blocker in HFpEF: A Reappraisal
Ray, S., Ray, S., Yadav, S., & Naik, N. (2026) · Indian Heart Journal · doi:10.1016/j.ihj.2026.08.004
Seth, S., Chopra, V., Sinha, N., Nair, T., Böhm, M., Sawhney, J. P. S., Oomman, A., Jaswal, A., Gopi, A., Rao, S., et al. (2026) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_64_26
Chen, J., Ling, G., Fang, C., Wu, Z., Ye, S., Huang, Z., Luo, C., & Zheng, B. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm48668
Ahmed, M. (2025) · Journal of Prevention Diagnosis and Management of Human Diseases · doi:10.55529/jpdmhd.52.95.108
An, Y., Shang, C., El‐Aty, A. M. A., Reiter, R. J., Tuomilehto, J., Qin, X., Dhanasekaran, M., Uversky, V. N., Haidara, M. A., Zhao, L., et al. (2026) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2026.84 · Cited by 1
Oishi, Y. (2025) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.114.1656
Integration of multiple perspectives to understand the left ventricular pressure–volume relationship
Tonti, G., Pedrizzetti, G., & Salustri, A. (2026) · Communications Medicine · doi:10.1038/s43856-026-01901-2
Li, J., Zhou, G., Wang, Q., Song, Z., Liu, J., Shen, C., Luo, C., & Wang, D. (2026) · PLoS ONE · doi:10.1371/journal.pone.0357886
Copeland, V., Milwidsky, A., Elimeleh, S., Makmal, N., Loutati, R., Zwilling, M., Fishman, B., Wasserstrum, Y., Segev, A., Maor, E., et al. (2026) · The American Journal of Medicine · doi:10.1016/j.amjmed.2026.09.006
Wang, X., Chen, Z., Wen, F., Guo, C., Jiang, F., Bi, J., Wang, D., & Jiang, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1940865
Bell, A., Mena, J. G., Ausiello, A., Clainche, S. L., Orero, M. V., & Lara‐Pezzi, E. (2026) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-026-10832-1
Li, X., Fu, Y., do Carmo, J. M., da Silva, A. A., Mouton, A. J., Omoto, A. C. M., Wang, L., Hall, J. E., & Wang, Z. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00304.2026
Ausiello, A., Lalaguna, L., López-Olañeta, M. M., Torroja, C., Palacios-Merino, J., Sánchez‐Cabezudo, C., Rivas, P., Villalba‐Orero, M., Fernandez-Cortes, E., García‐Pavía, P., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag193 · Cited by 1
Li, Q., Yang, T., Jin, G., & Zhou, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1930278
Engineering the geriatric heart to model HFpEF
Bass-Stringer, S., Lees, J. G., & Lim, S. Y. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10683-7
Wang, J., An, S., Wang, Z., Hu, Z., Zhang, Y., Jia, D., Cheng, Y., Xiang, Y., Fang, R., Zheng, P., et al. (2026) · Frontiers in Radiology · doi:10.3389/fradi.2026.1912855
Eisa, N., & Khoury, M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag284
Cline, L. (2026) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001370
Graczyk, P., Keller, D. M., & Kuźnar-Kamińska, B. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1954683
Interatrial Shunt Devices in Heart Failure: A Therapy in Search of the Right Patient
Karagianni, A., Evangeliou, A. P., Pavlou, D. O., Schismenos, V., Pagourelias, E. D., Γιαννόπουλος, Γ., Papadopoulos, C. E., Karamitsos, T. D., Vassilikos, V. P., & Tzikas, S. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13100519
Digital hearts: advancing cardiovascular health through data-science-driven clinical translation
Hu, Y., Shao, X.-J., & Song, J.-P. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100074
Zhao, Y., Zhang, L., Feng, L., Xi, Y., 蔡梦昕, & Tian, Z. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107078
BindingDB Entry 50014592: Identification of 6-Hydroxypyrimidin-4(1
BindingDB (2022) · UC San Diego · doi:10.7270/q2m330mf
Al-Harbi, F. A., Alawaji, H. H., Alhabdan, H. S., Alsultan, N. S., Alrebdi, D. A., AlMutairi, O. H., Alharbi, F. M., & Alosail, A. F. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001523
Metadata
- Authors
- Borlaug, B. A.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Borlaug, Barry A.
- ORCID
- Borlaug, Barry A.
- Venue
- Nature Reviews Cardiology
- Published
- 2020-03-30
- Volume
- 17
- Issue
- 9
- Pages
- 559-573
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W3013711965
- Cited by
- 675
- References
- 180
- Citations by year
- 2026: 97 · 2025: 104 · 2024: 130 · 2023: 132 · 2022: 120 · 2021: 71 · 2020: 19
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL128526, U01HL125205)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- heart failure with preserved ejection fraction, HFpEF diagnosis, diuretics, mineralocorticoid receptor antagonists, lifestyle intervention, phenotypic subgroups, personalized treatment, diastolic dysfunction, aging, obesity, diabetes mellitus, hypertension
- MeSH terms
- Heart Failure, Humans, Middle Aged, Stroke Volume
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
